 |
|
|
There are moments in life, when time stops and everything is affected from that moment forward. News & Events Tribute to Sue McCollumNovember 28, 2022
Sue McCollum founded My Blue Dots based upon the founding principle that cancer would be...  My Blue Dots Bell Ringing CeremonyJuly 22, 2020 A New Tradition at the Radiation Oncology at Stanford University
[caption...  We give – Dr. Erinn RankinJuly 22, 2020
Imagine if we could improve patient outcomes by selectively eliminating the most...  We inform – Dr Everett ModingJuly 20, 2020
Everett Moding, MD, PhD recently joined the staff in the Department of Radiation...  We honor Dr. Quynh-Thu LeJuly 20, 2020
Dr. Quynh-Thu Le, Chair of the Radiation Oncology Department of Stanford University, is... We honorcancer warriors and those who support them.Dr. Quynh-Thu Le, Chair of the Radiation Oncology Department of Stanford University, is who we would like to honor. Dr Le brings to her patients not only deep knowledge of their cancer but also a kind, compassionate bedside manner. Her research is in the field of head and neck cancer and she and her team are making new discovering in the laboratory and clinic each day. We honor this remarkable doctor and thank her for her service. Read her story...We informothers by highlighting new discoveries in cancer research.Everett Moding, MD, PhD recently joined the staff in the Department of Radiation Oncology at Stanford University. Dr. Moding has a gentle and supportive presence with his patients in his clinical work. He is well liked by his patients as well as the staff. His research is innovative and is opening up new discoveries in the treatment of cancer and he is currently setting up his lab at Stanford. Read his story...We giveto cancer research and cancer support programs.Imagine if we could improve patient outcomes by selectively eliminating the most aggressive cancer cells. Dr. Rankin and her team are working to develop novel therapies for advanced cancers. As a post-doctoral fellow, Dr. Rankin was part of the team that identified a link between the AXL signaling pathway and metastatic cancers including advanced breast, ovarian and kidney cancers. Read her story... |
|
  |
